Results
1 -
5 of
5Ortqvist P; Peterson SD; Kerblom E; Gossas T; Sabnis YA; Fransson R; Lindeberg G; Helena Danielson U; Karl?n A; Sandstr?m A.
Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors., Bioorganic & medicinal chemistry In Vivo Study of HCV in Mice with Chimeric Human Livers, Hepatitis C Pharmacotherapy for a Phantom Menace, Pharmaceutical & Diagnostic Innovation Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease Inhibitors, The Protein Journal Treatment of chronic hepatitis C: Anticipated impact of resistance in patients treated with protease inhibitors, Current Gastroenterology Reports